Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden
· Delayed Price · Currency is SEK 47.55
-2.55 (-5.09%)
Mar 9, 2026, 2:51 PM CET
STO:IBT.B Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
646.63M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medivir AB | 8.50M |
| FluoGuide | 318.79K |
| Xspray Pharma AB | 6.43M |
| Cantargia AB | 316.70M |
| Oncopeptides AB | 71.12M |
| Genovis AB (publ.) | 129.65M |
| Corline Biomedical AB | 8.59M |
| Elicera Therapeutics AB | 10.86M |